About Dr. Miller
An alumna of Yale University School of Medicine, Dr. Miller completed her internship and residency at NewYork-Presbyterian/Weill-Cornell Medical Center and MSK. Her fellowship was at MSK, where she was also the chief neurology resident and chief neuro-oncology fellow.
Ad Statistics
Times Displayed: 124471
Times Visited: 7225 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Dr. Miller is an active member of several professional societies, including the American Academy of Neurology, the Society for Neuro-Oncology, the American Society of Clinical Oncology, and the American Association for Cancer Research. She has also authored and co-authored research in top-tier publications, including Nature, Neuro-Oncology, Neurology, and The Journal of Neuroscience.
Her primary research focuses on diffuse glioma and unraveling the molecular changes underlying progression to lethality. In 2019, she led a study that explored the use of cerebrospinal fluid (CSF) as a liquid biopsy in diffuse glioma for diagnosis, disease monitoring, and tracking tumor evolution. The researchers were able to detect tumor-derived DNA (ctDNA) in the CSF of patients who had had a lumbar puncture for clinical indications. The detection of CSF ctDNA was correlated with tumor burden, progression of disease, and an increased rate of death.
Back to HCB News
